Jim Cramer Recently Talked About These 19 Stocks

11. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 93

Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that he liked its quarter. He remarked:

“What do we make of the numbers that we got from Merck this morning? The pharma titan reported what some thought was a mixed quarter. I actually liked it. Small revenue miss, paired with an 11-cent earnings beat. Stock got hit, finishing the day down nearly 2% although it was a lot lower at one point.

Merck’s had a tough time over the past year, falling 45% from its highs in June of 2024 before recovering only modestly over the past couple weeks. Wall Street seems to be worried about that looming patent cliff for their blockbuster… best drug ever, Keytruda, which accounts for about half of the company’s sales. Doesn’t help that GARDASIL, their HPV vaccines, really struggled thanks to persistent weakness in China… While Merck’s made some excellent acquisitions to expand the drug pipeline, stock hasn’t gotten much credit for it. I think that’s wrong.”

Merck (NYSE:MRK) develops and sells pharmaceuticals for human and animal health, covering areas such as oncology, vaccines, virology, and livestock care. The company also holds multiple collaboration and licensing agreements to advance treatments across various medical conditions.